Essai clinique
Récupéré
Publication
clinicaltrials.gov
Massachusetts General Hospital
(2013).
An Open-Label Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders.
ClinicalTrials.gov.
Massachusetts General Hospital.
- Date de publication
-
2013
- Identifiant
-
NCT01850355
- Auteurs
-
Massachusetts General Hospital
- Source
- ClinicalTrials.gov
- Type de référence
- clinical_trial
- Éditeur
- Massachusetts General Hospital
- Source de métadonnées
- clinicaltrials.gov
Résumé
The main objective of this exploratory 8-week pilot study is to evaluate the safety and efficacy of buspirone for the treatment of anxiety in youth (ages 6-17 years) with autism spectrum disorders. The study results will be used to generate hypothesis for a larger randomized controlled clinical trials with explicit hypotheses and sufficient statistical power.